Search clinical trials for: CDD

Total 2384 results

New York City Department of Health and Mental Hygiene
Agency for Healthcare Research and Quality (AHRQ); NYU

Active, not recruiting

Practice Facilitation to Scale up a CDS for Hypertension Management

Hypertension

United States
Children's Hospital of Philadelphia

Active, not recruiting

Efficacy of Clinical Decision Support and Sleep Navigation (Sleep PASS)

Sleep | Obstructive Sleep Apnea | Sleep-Disordered Breathing

United States
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029

Type 2 Diabetes

Korea, Republic of
Centre for Probe Development and Commercialization

Completed

A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours

Cancer

Canada
Advanced Pain and Rehab Specialists
Hemp synergistics

Not yet recruiting

The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management

Insomnia | Anxiety | Opioid Use | Pain, Chronic | CBD

United States
Chong Kun Dang Pharmaceutical

Completed

Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects

Healthy Volunteers

France
National Cancer Institute (NCI)

Completed

Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Evangelismos Hospital
Agricultural University of Athens

Recruiting

The Crohn's Disease Exclusion Diet With Early Dairy Introduction Plus Partial Enteral Nutrition for Crohn's Disease (CD-EDEN)

Crohn Disease

Greece
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)

Hypertension | Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

Hypertension and Dyslipidemia

Korea, Republic of
Washington University School of Medicine
National Cancer Institute (NCI); The Foundation for Barnes-Jewish Hospital; Celldex...

Terminated

Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients

Pancreatic Cancer | Pancreas Cancer | Cancer of the Pancreas

United States
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)

Hypertension and Dyslipidemia

Korea, Republic of
University of California, Irvine

Completed

A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers

Cerebral Ischemia

United States
American Academy of Family Physicians
University of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaborators

Completed

Improving Evidence-Based Primary Care for Chronic Kidney Disease

Chronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, Chronic

United States
University of Texas at Austin

Suspended

Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder

Post Traumatic Stress Disorder

United States
Vanderbilt University Medical Center
National Institute of Nursing Research (NINR); National Institutes of Health...

Recruiting

Imaging Biomarkers of Lymphatic Dysfunction

Secondary Lymphedema

United States
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics and Safety Profile of CKD-333

Hypertension | Dyslipidemias

Korea, Republic of
Attikon Hospital

Recruiting

A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases

Cancer | Brain

Greece
Children's Hospital Medical Center, Cincinnati

Completed

Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease

Congenital Heart Disease | Nutritional Failure

United States
Chong Kun Dang Pharmaceutical

Completed

A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions

Type2Diabetes

Korea, Republic of
Cocrystal Pharma, Inc.

Completed

A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects

Hepatitis C

Canada
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150 (CKD-383)

Type 2 Diabetes

Korea, Republic of
Laval University
Danone Institute International

Completed

Impact of Cognitive Dietary Restraint on Perceived Stress, Appetite Sensations, Food Cravings During Energy Restriction

Overweight

Canada
Abramson Cancer Center at Penn Medicine
Patient-Centered Outcomes Research Institute

Recruiting

Comparing Two Ways to Manage Head and Neck Lymphedema

Head and Neck Cancer | Lymphedema

United States
Chong Kun Dang Pharmaceutical

Unknown

A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects

GERD

Korea, Republic of
Fox Chase Cancer Center
Knowledge Networks

Completed

Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA Men

Prostate Cancer

United States
Chong Kun Dang Pharmaceutical

Completed

A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects

Healthy Volunteers

United States
Duke University
American Heart Association

Terminated

Pacing Affects Cardiovascular Endpoints in Patients With Right Bundle-Branch Block (The PACE-RBBB Trial) (PACE-RBBB)

Heart Failure | Right Bundle-Branch Block

United States
National Cancer Institute (NCI)

Completed

Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Fallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer

United States
National Cancer Institute (NCI)

Completed

CDDO to Treat Solid Tumors and Lymphomas

Lymphoma | Solid Tumors

United States
Oregon Health and Science University
University of Missouri-Columbia; Vanderbilt University Medical Center

Recruiting

Collaboration Oriented Approach to Controlling High Blood Pressure (COACH)

Hypertension | Multiple Chronic Conditions

United States
National Institute of Allergy and Infectious Diseases...
University of Pittsburgh; PPD

Completed

Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant (BOLT-BMT)

Primary Immunodeficiency | PID

United States
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics and Safety/Tolerability Profile of CKD-379

Type II Diabetes Mellitus

Korea, Republic of
Pure Green

Recruiting

Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
University of Bergen
Nofima; Granit AS Transport & Tourism; Norwegian Seafood Center

Completed

A Study of the Effects of Intake of Two Cod Residual Meals on Glucose Regulation in Overweight and Obese Adults (FISK4)

Obesity | Overweight

Norway
Mahidol University
University of Medical Technology, Yangon

Completed

Improving Clinical Decision Making Skills for Myanmar Physical Therapists by Series of Workshop

Cognitive Change

Myanmar
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases

Autoimmune Diseases | Crohn Disease | Ulcerative Colitis | Dermatomyositis | Still Disease

China
University of Calgary

Not yet recruiting

Cannabis for the Prophylactic Treatment of Migraine

Chronic Migraine
Chong Kun Dang Pharmaceutical

Completed

Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Unspecified Adult Solid Tumor, Protocol Specific

Korea, Republic of
Chong Kun Dang Pharmaceutical
Seoul National University Hospital

Completed

Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Unspecified Adult Solid Tumor, Protocol Specific

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects

Hypertension | Dyslipidemias

Korea, Republic of
National Cancer Institute (NCI)

Completed

Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer

Stage IV Gastric Cancer | Stage III Gastric Cancer

United States
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519

Healthy Volunteers

Korea, Republic of
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Withdrawn

Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer

Tongue Cancer | Stage III Squamous Cell Carcinoma of the Oropharynx | Stage IVA Squamous Cell Carcinoma of the Oropharynx

United States
Brigham and Women's Hospital
National Institutes of Health (NIH); National Institute on Aging (NIA)

Recruiting

Electronic Strategies for Tailored Exercise to Prevent FallS (eSTEPS)

Fall Injury | Falls | Exercise Self-Efficacy | Falls Self-Efficacy

United States
Tel-Aviv Sourasky Medical Center

Recruiting

Prospective Dietary Therapy Using Crohn's Disease Exclusion Diet for Ileal Pouch Anal Anastomosis Patients

Pouchitis | Crhon's Disease Like of the Pouch

Israel
Cairo University

Active, not recruiting

Different Level of ECSWT in Post Mastectomy Lymphedema

Lymphedema of Upper Limb

Egypt
Cadent Therapeutics

Completed

A Clinical Study to Evaluate CAD-1883 in Essential Tremor

Essential Tremor

United States

Search clinical trials for: CDD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations